Updates in the field of hereditary nonpolyposis colorectal cancer

References

• Thompson BA, Spurdle AB, Plazzer JP, et al. Application of a 5-tiered scheme for standardized classification of 2.360 unique mismatch repair gene variants in the InSiGHT locus-specific database. Nat Genet. 2014;46(2): 107–115.
   PubMed Web of Science ®Google Scholar
• Haraldsdottir S, Rafnar T, Frankel WL, et al. Comprehensive population-wide analysis of lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2. Nat. Commun. 2017;8(1):14755.
   PubMedGoogle Scholar
• Hampel H, de la Chapelle A. How do we approach the goal of identifying everybody with lynch syndrome? Fam. Cancer. 2013;12(2):313–317.
   PubMed Web of Science ®Google Scholar
• Manhart CM, Alani E. Roles for mismatch repair family proteins in promoting meiotic crossing over. DNA Repair (Amst). 2016;38:84–93.
   PubMed Web of Science ®Google Scholar
• Jiricny J. Postreplicative mismatch repair. Cold Spring Harb. Perspect. Biol. 2013;5(4):a012633.
   PubMed Web of Science ®Google Scholar
• Peltomäki P. Update on lynch syndrome genomics. Fam. Cancer. 2016;15(3):385–393.
   PubMed Web of Science ®Google Scholar
• Dominguez-Valentin M, Sampson JR, Seppälä TT, et al. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the prospective lynch syndrome database. Genet Med. 2020;22(1): 15–25.
   PubMed Web of Science ®Google Scholar
• Ten Broeke SW, van Bavel TC, Jansen AML, et al. Molecular background of colorectal tumors from patients with lynch syndrome associated with germline variants in PMS2. Gastroenterology. 2018;155(3): 844–851.
   PubMed Web of Science ®Google Scholar
• Engel C, Ahadova A, Seppälä TT, et al. Associations of pathogenic variants in MLH1, MSH2, and MSH6 with risk of colorectal adenomas and tumors and with somatic mutations in patients with lynch syndrome. Gastroenterology. 2020;158(5): 1326–1333.
   PubMed Web of Science ®Google Scholar
• Mangold E, Pagenstecher C, Friedl W, et al. Spectrum and frequencies of mutations inMSH2 andMLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer. Int J Cancer. 2005;116(5):692–702.
   PubMed Web of Science ®Google Scholar
• Lagerstedt Robinson K, Liu T, Vandrovcova J, et al. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J. Natl. Cancer Inst. 2007;99(4):291–299.
   PubMedGoogle Scholar
• Wijnen J, Khan PM, Vasen H, et al. Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations. Am J Hum Genet. 1997;61(2):329–335.
   PubMed Web of Science ®Google Scholar
• Pearlman R, Frankel WL, Swanson B, et al. Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol. 2017;3(4):464.
   PubMed Web of Science ®Google Scholar
• Espenschied CR, LaDuca H, Li S, et al. Multigene panel testing provides a new perspective on lynch syndrome. J. Clin. Oncol. 2017;35(22):2568–2575.
   PubMed Web of Science ®Google Scholar
• Ligtenberg MJL, Kuiper RP, Chan TL, et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1. Nat. Genet. 2009;41(1):112–117.
   PubMed Web of Science ®Google Scholar
• Kovacs ME, Papp J, Szentirmay Z, et al. Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome. Hum Mutat. 2009;30(2):197–203.
   PubMed Web of Science ®Google Scholar
• Cini G, Carnevali I, Quaia M, et al. Concomitant mutation and epimutation of the MLH1 gene in a lynch syndrome family. Carcinogenesis. 2015;36(4):452–458.
   PubMed Web of Science ®Google Scholar
• Morak M, Koehler U, Schackert HK, et al. Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndrome. J. Med. Genet. 2011;48(8):513–519.
   PubMed Web of Science ®Google Scholar
• Morak M, Ibisler A, Keller G, et al. Comprehensive analysis of the MLH1 promoter region in 480 patients with colorectal cancer and 1150 controls reveals new variants including one with a heritable constitutional MLH1 epimutation. J Med Genet. 2018;55(4):240–248.
   PubMed Web of Science ®Google Scholar
• Gylling A, Ridanpää M, Vierimaa O, et al. Large genomic rearrangements and germline epimutations in Lynch syndrome. Int. J. Cancer. 2009;124(10):2333–2340.
   PubMed Web of Science ®Google Scholar
• Morak M, Schackert HK, Rahner N, et al. Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC. Eur. J. Hum. Genet. 2008;16(7):804–811.
   PubMed Web of Science ®Google Scholar
• Ward RL, Dobbins T, Lindor NM, et al. Identification of constitutional MLH1 epimutations and promoter variants in colorectal cancer patients from the Colon Cancer Family Registry. Genet. Med. 2013;15(1):25–35.
   PubMed Web of Science ®Google Scholar
• Niessen RC, Hofstra RMW, Westers H, et al. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome. Genes. Chromosomes Cancer. 2009;48(8):737–744.
   PubMed Web of Science ®Google Scholar
• Leclerc J, Flament C, Lovecchio T, et al. Diversity of genetic events associated with MLH1 promoter methylation in Lynch syndrome families with heritable constitutional epimutation. Genet Med. 2018;20(12): 1589–1599.
   PubMed Web of Science ®Google Scholar
• Castillejo A, Hernández-Illán E, Rodriguez-Soler M, et al. Prevalence of MLH1 constitutional epimutations as a cause of Lynch syndrome in unselected versus selected consecutive series of patients with colorectal cancer. J Med Genet. 2015;52(7):498–502.
   PubMed Web of Science ®Google Scholar
• Dámaso E, Canet-Hermida J, Vargas-Parra G, et al. Highly sensitive MLH1 methylation analysis in blood identifies a cancer patient with low-level mosaic MLH1 epimutation. Clin Epigenetics. 2019;11(1):171.
   PubMed Web of Science ®Google Scholar
• Liu Y, Chew MH, Goh XW, et al. Systematic study on genetic and epimutational profile of a cohort of amsterdam criteria-defined lynch syndrome in Singapore. Suzuki H, editor. PLoS ONE. 2014;9(4):e94170.
   PubMed Web of Science ®Google Scholar
• Kidambi TD, Blanco A, Van Ziffle J, et al. Constitutional MLH1 methylation presenting with colonic polyposis syndrome and not Lynch syndrome. Fam Cancer. 2016;15(2):275–280.
   PubMed Web of Science ®Google Scholar
• Kempers MJ, Kuiper RP, Ockeloen CW, et al. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol. 2011;12(1):49–55.
   PubMed Web of Science ®Google Scholar
• Hitchins M, Williams R, Cheong K, et al. MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. Gastroenterology. 2005;129(5):1392–1399.
   PubMed Web of Science ®Google Scholar
• Huth C, Kloor M, Voigt AY, et al. The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors. Mod. Pathol. 2012;25(6):911–916.
   PubMed Web of Science ®Google Scholar
• Nagasaka T, Rhees J, Kloor M, et al. Somatic hypermethylation of MSH2 Is a frequent event in lynch syndrome colorectal cancers. Cancer Res. 2010;70(8):3098–3108.
   PubMed Web of Science ®Google Scholar
• Hitchins MP, Wong JJL, Suthers G, et al. Inheritance of a cancer-associated MLH1 germ-line epimutation. N. Engl. J. Med. 2007;356(7):697–705.
   PubMed Web of Science ®Google Scholar
• Sloane MA, Nunez AC, Packham D, et al. Mosaic epigenetic inheritance as a cause of early-onset colorectal cancer. JAMA Oncol. 2015;1(7):953–957.
   PubMed Web of Science ®Google Scholar
• Dámaso E, Castillejo A, Arias M, et al. Primary constitutional MLH1 epimutations: a focal epigenetic event. Br J Cancer. 2018;119(8):978–987.
   PubMed Web of Science ®Google Scholar
• Hitchins MP, Rapkins RW, Kwok C-T, et al. Dominantly inherited constitutional epigenetic silencing of MLH1 in a cancer-affected family is linked to a single nucleotide variant within the 5′UTR. Cancer Cell. 2011;20(2):200–213.
   PubMed Web of Science ®Google Scholar
• Porkka N, Lahtinen L, Ahtiainen M, et al. Epidemiological, clinical and molecular characterization of Lynch‐like syndrome: A population‐based study. Int. J. Cancer. 2019;145(1):87–98.
   PubMed Web of Science ®Google Scholar
• Pasanen A, Loukovaara M, Bützow R. Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma. Mod Pathol. 2020; In press. doi:10.1038/s41379-020-0501-8.
   PubMed Web of Science ®Google Scholar
• Rodríguez–Soler M, Pérez–Carbonell L, Guarinos C, et al. Risk of cancer in cases of suspected lynch syndrome without germline mutation. Gastroenterology. 2013;144(5):926–932.
   PubMed Web of Science ®Google Scholar
• Geurts-Giele WR, Leenen CH, Dubbink HJ, et al. Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers: somatic MMR aberrations cause Lynch syndrome-like tumours. J. Pathol. 2014;234(4):548–559.
   PubMed Web of Science ®Google Scholar
• Haraldsdottir S, Hampel H, Tomsic J, et al. Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. Gastroenterology. 2014;147(6):1308–1316.
   PubMed Web of Science ®Google Scholar
• Mensenkamp AR, Vogelaar IP, van Zelst–stams WAG, et al. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in lynch syndrome-like tumors. Gastroenterology. 2014;146(3):643–646.
   PubMed Web of Science ®Google Scholar
• Pearlman R, Haraldsdottir S, de la Chapelle A, et al. Clinical Characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome. J. Med. Genet. 2019;56(7):462–470.
   PubMed Web of Science ®Google Scholar
• Mas-Moya J, Dudley B, Brand RE, et al. Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome. Hum. Pathol. 2015;46(11):1616–1625.
   PubMed Web of Science ®Google Scholar
• Picó MD, Castillejo A, Murcia Ó, et al. Clinical and pathological characterization of lynch-like syndrome. Clin. Gastroenterol. Hepatol. 2020;18(2):368–374.
   PubMed Web of Science ®Google Scholar
• Vargas-Parra GM, González-Acosta M, Thompson BA, et al. Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis: molecular basis of MSH2-deficient tumors. Int. J. Cancer. 2017;141(7):1365–1380.
   PubMed Web of Science ®Google Scholar
• Xicola RM, Clark JR, Carroll T, et al. Implication of DNA repair genes in Lynch-like syndrome. Fam. Cancer. 2019;18(3):331–342.
   PubMed Web of Science ®Google Scholar
• Wimmer K, Etzler J. Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? Hum. Genet. 2008;124(2):105–122.
   PubMed Web of Science ®Google Scholar
• Bakry D, Aronson M, Durno C, et al. Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium. Eur J Cancer. 2014;50(5):987–996.
   PubMed Web of Science ®Google Scholar
• Bodo S, Colas C, Buhard O, et al. Diagnosis of constitutional mismatch repair-deficiency syndrome based on microsatellite instability and lymphocyte tolerance to methylating agents. Gastroenterology. 2015;149(4):1017–1029.
   PubMed Web of Science ®Google Scholar
• Wang Q, Montmain G, Ruano E, et al. Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type. Hum. Genet. 2003;112(2):117–123.
   PubMed Web of Science ®Google Scholar
• Gallon R, Mühlegger B, Wenzel -S-S, et al. A sensitive and scalable microsatellite instability assay to diagnose constitutional mismatch repair deficiency by sequencing of peripheral blood leukocytes. Hum. Mutat. 2019;40(5):649–655.
   PubMed Web of Science ®Google Scholar
• González-Acosta M, Marín F, Puliafito B, et al. High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriers. J. Med. Genet. 2020;57(4):269–273.
   PubMed Web of Science ®Google Scholar
• Goodenberger ML, Thomas BC, Riegert-Johnson D, et al. PMS2 monoallelic mutation carriers: the known unknown. Genet. Med. 2016;18(1):13–19.
   PubMed Web of Science ®Google Scholar
• Levi Z, Kariv R, Barnes-Kedar I, et al. The gastrointestinal manifestation of constitutional mismatch repair deficiency syndrome: from a single adenoma to polyposis-like phenotype and early onset cancer: the gastrointestinal phenotype of CMMRD. Clin. Genet. 2015;88(5):474–478.
   PubMed Web of Science ®Google Scholar
• Durno C, Boland CR, Cohen S, et al. Recommendations on surveillance and management of biallelic mismatch repair deficiency (BMMRD) syndrome: a consensus statement by the US multi-society task force on colorectal cancer. Gastroenterology. 2017;152(6):1605–1614.
   PubMed Web of Science ®Google Scholar
• Adam R, Spier I, Zhao B, et al. Exome sequencing identifies biallelic MSH3 germline mutations as a recessive subtype of colorectal adenomatous polyposis. Am J Hum Genet. 2016;99(2):337–351.
   PubMed Web of Science ®Google Scholar
• Olkinuora A, Nieminen TT, Mårtensson E, et al. Biallelic germline nonsense variant of MLH3 underlies polyposis predisposition. Genet. Med. 2019;21(8):1868–1873.
   PubMed Web of Science ®Google Scholar
• Wu Y, Berends MJ, Sijmons RH, et al. A role for MLH3 in hereditary nonpolyposis colorectal cancer. Nat. Genet. 2001;29(2):137–138.
   PubMed Web of Science ®Google Scholar
• Liu H-X, Zhou X-L, Liu T, et al. The role of hMLH3 in familial colorectal cancer. Cancer Res. 2003;63(8):1894–1899.
   PubMed Web of Science ®Google Scholar
• Shlien A, Campbell BB, de Borja R, et al. Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers. Nat. Genet. 2015;47(3):257–262.
   PubMed Web of Science ®Google Scholar
• Siraj AK, Masoodi T, Bu R, et al. The study of Lynch syndrome in a special population reveals a strong founder effect and an unusual mutational mechanism in familial adenomatous polyposis. Gut. 2020;18(2):368–374.e1.
   Google Scholar
• Vasen HF, Mecklin JP, Khan PM, et al. The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis. Colon Rectum. 1991;34(5):424–425.
   PubMed Web of Science ®Google Scholar
• Vasen HF, Watson P, Mecklin JP, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 1999;116(6):1453–1456.
   PubMed Web of Science ®Google Scholar
• Lindor NM, Rabe K, Petersen GM, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 2005;293(16):1979–1985.
   PubMed Web of Science ®Google Scholar
• Vasen HFA, Boland CR. Progress in genetic testing, classification, and identification of Lynch syndrome. JAMA. 2005;293(16):2028–2030.
   PubMed Web of Science ®Google Scholar
• Dominguez-Valentin M, Therkildsen C, Da Silva S, et al. Familial colorectal cancer type X: genetic profiles and phenotypic features. Mod. Pathol. 2015;28(1):30–36.
   PubMed Web of Science ®Google Scholar
• Goel A, Xicola RM, Nguyen T, et al. Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. Gastroenterology. 2010;138(5):1854–1862.
   PubMed Web of Science ®Google Scholar
• Sahnane N, Magnoli F, Bernasconi B, et al. Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer. Clin. Epigenetics. 2015;21(1):131.
   Google Scholar
• Pavicic W, Joensuu EI, Nieminen T, et al. LINE-1 hypomethylation in familial and sporadic cancer. J Mol Med. 2012;90(7):827–835.
   PubMed Web of Science ®Google Scholar
• Skoglund J, Djureinovic T, Zhou X-L, et al. Linkage analysis in a large Swedish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 9q22.32-31.1. J Med Genet. 2006;43(8):685–690.
   Google Scholar
• Gray-McGuire C, Guda K, Adrianto I, et al. Confirmation of Linkage to and Localization of Familial Colon Cancer Risk Haplotype on Chromosome 9q22. Cancer Res. 2010;70(13):5409–5418.
   PubMed Web of Science ®Google Scholar
• Thutkawkorapin J, Mahdessian H, Barber T, et al. Two novel colorectal cancer risk loci in the region on chromosome 9q22.32. Oncotarget. 2018;9(13):11170–11179.
   PubMedGoogle Scholar
• Guda K, Moinova H, He J, et al. Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers. Proc. Natl. Acad. Sci. 2009;106(31):12921–12925.
   PubMed Web of Science ®Google Scholar
• Clarke E, Green RC, Green JS, et al. Inherited deleterious variants in GALNT12 are associated with CRC susceptibility. Hum Mutat. 2012;33(7):1056–1058.
   PubMed Web of Science ®Google Scholar
• Evans DR, Venkitachalam S, Revoredo L, et al. Evidence for GALNT12 as a moderate penetrance gene for colorectal cancer. Hum Mutat. 2018;39(8):1092–1101.
   PubMed Web of Science ®Google Scholar
• Seguí N, Pineda M, Navarro M, et al. GALNT12 is not a major contributor of familial colorectal cancer type x. Hum Mutat. 2014;35(1):50–52.
   PubMed Web of Science ®Google Scholar
• Nieminen TT, O’Donohue M-F, Wu Y, et al. Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency. Gastroenterology. 2014;147(3): 595–598. .
   PubMed Web of Science ®Google Scholar
• Broderick P, Dobbins SE, Chubb D, et al. Validation of recently proposed colorectal cancer susceptibility gene variants in an analysis of families and patients-a systematic review. Gastroenterology. 2017;152(1):75–77.
   PubMed Web of Science ®Google Scholar
• Thompson BA, Snow AK, Koptiuch C, et al. A novel ribosomal protein S20 variant in a family with unexplained colorectal cancer and polyposis. Clin Genet. 2020;97(6):943-944.
   Google Scholar
• Amsterdam A, Sadler KC, Lai K, et al. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol. 2004;2(5):E139.
   PubMed Web of Science ®Google Scholar
• Ajore R, Raiser D, McConkey M, et al. Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with TP 53 mutations. EMBO Mol Med. 2017;9(4):498–507.
   PubMed Web of Science ®Google Scholar
• Aspesi A, Ellis SR. Rare ribosomopathies: insights into mechanisms of cancer. Nat. Rev. Cancer. 2019;19(4):228–238.
   PubMed Web of Science ®Google Scholar
• Gazda HT, Preti M, Sheen MR, et al. Frameshift mutation in p53 regulator RPL26 is associated with multiple physical abnormalities and a specific pre-ribosomal RNA processing defect in diamond-blackfan anemia. Hum Mutat. 2012;33(7):1037–1044.
   PubMed Web of Science ®Google Scholar
• Vlachos A, Rosenberg PS, Atsidaftos E, et al. Increased risk of colon cancer and osteogenic sarcoma in Diamond-Blackfan anemia. Blood. 2018;132(20):2205–2208.
   PubMed Web of Science ®Google Scholar
• McGowan KA, Li JZ, Park CY, et al. Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat. Genet. 2008;40(8):963–970.
   PubMed Web of Science ®Google Scholar
• Khajuria RK, Munschauer M, Ulirsch JC, et al. Ribosome levels selectively regulate translation and lineage commitment in human hematopoiesis. Cell. 2018;173(1):90–103.
   PubMed Web of Science ®Google Scholar
• Bellido F, Sowada N, Mur P, et al. Association between germline mutations in BRF1, a subunit of the RNA polymerase iii transcription complex, and hereditary colorectal cancer. Gastroenterology. 2018;154(1): 181–194.
   PubMed Web of Science ®Google Scholar
• Wang W, Nag S, Zhang X, et al. Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications. Med Res Rev. 2015;35:225–285.
   PubMed Web of Science ®Google Scholar
• Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J. Natl. Cancer Inst. 2004;96(4):261–268.
   PubMed Web of Science ®Google Scholar
• Seguí N, Mina LB, Lázaro C, et al. Germline mutations in FAN1 cause hereditary colorectal cancer by impairing DNA repair. Gastroenterology. 2015;149(3):563–566.
   PubMed Web of Science ®Google Scholar
• Zhou W, Otto EA, Cluckey A, et al. FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair. Nat. Genet. 2012;44(8):910–915.
   PubMed Web of Science ®Google Scholar
• Arora S, Yan H, Cho I, et al. Genetic variants that predispose to DNA double-strand breaks in lymphocytes from a subset of patients with familial colorectal carcinomas. Gastroenterology. 2015;149(7):1872–1883.
   PubMed Web of Science ®Google Scholar
• Lauper JM, Krause A, Vaughan TL, et al. Spectrum and risk of neoplasia in Werner syndrome: a systematic review. Burk RD, editor. PLoS ONE. 2013;8(4):e59709.
   PubMed Web of Science ®Google Scholar
• Hoeijmakers JHJ, Damage DNA. Aging, and Cancer. N. Engl. J. Med. 2009;361(15):1475–1485.
   PubMed Web of Science ®Google Scholar
• Chubb D, Broderick P, Dobbins SE, et al. Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer. Nat Commun. 2016;7(1): 11883.
   PubMedGoogle Scholar
• Shen E, Xiu J, Lopez GY, et al. POT1 mutation spectrum in tumour types commonly diagnosed among POT1 -associated hereditary cancer syndrome families. J Med Genet. 2020;jmedgenet-2019-106657. In press. doi:10.1136/jmedgenet-2019-106657.
   Google Scholar
• Spier I, Holzapfel S, Altmüller J, et al. Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas. Int J Cancer. 2015;137(2):320–331.
   PubMed Web of Science ®Google Scholar
• Bartkova J, Tommiska J, Oplustilova L, et al. Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene. Mol Oncol. 2008;2(4):296–316.
   PubMed Web of Science ®Google Scholar
• Waltes R, Kalb R, Gatei M, et al. Human RAD50 deficiency in a nijmegen breakage syndrome-like disorder. Am. J. Hum. Genet. 2009;84(5):605–616.
   PubMed Web of Science ®Google Scholar
• Bonjoch L, Franch-Expósito S, Garre P, et al. Germline mutations in FAF1 are associated with hereditary colorectal cancer. Gastroenterology. 2020; In press. doi:10.1053/j.gastro.2020.03.015.
   PubMed Web of Science ®Google Scholar
• Wang C-H, Hung P-W, Chiang C-W, et al. Identification of two independent SUMO-interacting motifs in Fas-associated factor 1 (FAF1): implications for mineralocorticoid receptor (MR)-mediated transcriptional regulation. Biochim Biophys Acta Mol Cell Res. 2019;1866(8):1282–1297.
   PubMed Web of Science ®Google Scholar
• Schulz E, Klampfl P, Holzapfel S, et al. Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X. Nat. Commun. 2014;5(1):5191.
   PubMedGoogle Scholar
• Kinnersley B, Chubb D, Dobbins SE, et al. Correspondence: SEMA4A variation and risk of colorectal cancer. Nat. Commun. 2016;7(1):10611.
   PubMedGoogle Scholar
• Nieminen TT, Abdel-Rahman WM, Ristimäki A, et al. BMPR1A mutations in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. Gastroenterology. 2011;141(1):23–26.
   Web of Science ®Google Scholar
• Latchford AR, Neale K, Phillips RKS, et al. Juvenile polyposis syndrome: a study of genotype, phenotype, and long-term outcome. Dis Colon Rectum. 2012;55(10):1038–1043.
   PubMed Web of Science ®Google Scholar
• Jacoby RF, Schlack S, Cole CE, et al. A juvenile polyposis tumor suppressor locus at 10q22 is deleted from nonepithelial cells in the lamina propria. Gastroenterology. 1997;112(4):1398–1403.
   PubMed Web of Science ®Google Scholar
• Auclair BA, Benoit YD, Rivard N, et al. Bone morphogenetic protein signaling is essential for terminal differentiation of the intestinal secretory cell lineage. Gastroenterology. 2007;133(3):887–896.
   PubMed Web of Science ®Google Scholar
• Fernandez-Rozadilla C, Brea-Fernández A, Bessa X, et al. BMPR1A mutations in early-onset colorectal cancer with mismatch repair proficiency. Clin Genet. 2013;84(1):94–96.
   PubMed Web of Science ®Google Scholar
• Rohlin A, Rambech E, Kvist A, et al. Expanding the genotype–phenotype spectrum in hereditary colorectal cancer by gene panel testing. Fam Cancer. 2017;16(2):195–203.
   PubMed Web of Science ®Google Scholar
• Lieberman S, Beeri R, Walsh T, et al. Variable features of juvenile polyposis syndrome with gastric involvement among patients with a large genomic deletion of BMPR1A. Clin. Transl. Gastroenterol. 2019;10(7):e00054.
   PubMedGoogle Scholar
• Evans DR, Green JS, Woods MO. Screening of BMPR1a for pathogenic mutations in familial colorectal cancer type X families from Newfoundland. Fam. Cancer. 2018;17(2):205–208.
   PubMed Web of Science ®Google Scholar
• Rahman N. Realizing the promise of cancer predisposition genes. Nature. 2014;505(7483):302–308.
   PubMed Web of Science ®Google Scholar
• Fletcher O, Houlston RS. Architecture of inherited susceptibility to common cancer. Nat. Rev. Cancer. 2010;10(5):353–361.
   PubMed Web of Science ®Google Scholar
• Nieminen TT, Pavicic W, Porkka N, et al. Pseudoexons provide a mechanism for allele-specific expression of APC in familial adenomatous polyposis. Oncotarget. 2016;7(43):70685–70698.
   PubMedGoogle Scholar
• Kim B-Y, Park JH, Jo H-Y, et al. Optimized detection of insertions/deletions (INDELs) in whole-exome sequencing data. PloS One. 2017;12(8):e0182272.
   PubMed Web of Science ®Google Scholar
• Serratì S, De Summa S, Pilato B, et al. Next-generation sequencing: advances and applications in cancer diagnosis. Oncol Targets Ther. 2016;9:7355–7365.
   PubMed Web of Science ®Google Scholar
• Sokolenko AP, Suspitsin EN, Kuligina ES, et al. Identification of novel hereditary cancer genes by whole exome sequencing. Cancer Lett. 2015;369(2):274–288.
   PubMed Web of Science ®Google Scholar
• Yurgelun MB, Allen B, Kaldate RR, et al. Identification of a variety of mutations in cancer predisposition genes in patients with suspected lynch syndrome. Gastroenterology. 2015;149(3):604–613.
   PubMed Web of Science ®Google Scholar
• Aretz S, Uhlhaas S, Sun Y, et al. Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene. Hum Mutat. 2004;24:370–380.
   PubMed Web of Science ®Google Scholar
• Alexandrov LB, Nik-Zainal S, Wedge DC, et al. Signatures of mutational processes in human cancer. Nature. 2013;500(7463):415–421.
   PubMed Web of Science ®Google Scholar
• Díaz-Gay M, Franch-Expósito S, Arnau-Collell C, et al. Integrated analysis of germline and tumor DNA identifies new candidate genes involved in familial colorectal cancer. Cancers (Basel). 2019;11(3):362.
   Web of Science ®Google Scholar
• Peters U, Bien S, Zubair N. Genetic architecture of colorectal cancer. Gut. 2015;64(10):1623–1636.
   PubMed Web of Science ®Google Scholar
• Zeng C, Matsuda K, Jia WH, et al. Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk. Gastroenterology. 2016;150(7):1633–1645.
   PubMed Web of Science ®Google Scholar
• Tenesa A, Dunlop MG. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat. Rev. Genet. 2009;10(6):353–358.
   PubMed Web of Science ®Google Scholar
• Stjepanovic N, Moreira L, Carneiro F, et al. Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2019;30(10):1558–1571.
   PubMed Web of Science ®Google Scholar
• Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet. Med. 2015;17(5):405–424.
   PubMed Web of Science ®Google Scholar
• Kansikas M, Kasela M, Kantelinen J, et al. Assessing how reduced expression levels of the mismatch repair genesMLH1,MSH2, and MSH6 affect repair efficiency. Hum Mutat. 2014;35(9):1123–1127.
   PubMed Web of Science ®Google Scholar
• Kasela M, Nyström M, Kansikas M. PMS2 expression decrease causes severe problems in mismatch repair.. Hum Mutat. 2019;40(7):904–907.
   PubMed Web of Science ®Google Scholar
• Binder H, Hopp L, Schweiger MR, et al. Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndrome: genomic and transcriptomic heterogeneity of Lynch syndrome in colon. J. Pathol. 2017;243(2):242–254.
   PubMed Web of Science ®Google Scholar
• Ahtiainen M, Wirta E-V, Kuopio T, et al. Combined prognostic value of CD274 (PD-L1)/PDCDI (PD-1) expression and immune cell infiltration in colorectal cancer as per mismatch repair status. Mod. Pathol. 2019;32(6):866–883.
   PubMed Web of Science ®Google Scholar
• Overman MJ, Lonardi S, Wong KYM, et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair–deficient/microsatellite instability–high metastatic colorectal cancer. J Clin Oncol. 2018;36(8):773–779.
   PubMed Web of Science ®Google Scholar
• von Knebel Doeberitz M, Kloor M. Towards a vaccine to prevent cancer in Lynch syndrome patients. Fam. Cancer. 2013;12(2):307–312.
   PubMed Web of Science ®Google Scholar
• Burn J, Sheth H, Elliott F, et al. Cancer prevention with aspirin in hereditary colorectal cancer (lynch syndrome), 10 year follow-up and registry based 20 year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial. Lancet. 2020;395(10240):1855–1863.
   PubMedGoogle Scholar
• The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Pan-cancer analysis of whole genomes. Nature. 2020;578(7793):82–93.
   PubMed Web of Science ®Google Scholar
• Vasen HFA, Tomlinson I, Castells A. Clinical management of hereditary colorectal cancer syndromes. Nat. Rev. Gastroenterol. Hepatol. 2015;12(2):88–97.
   PubMed Web of Science ®Google Scholar
• Therkildsen C, Rasmussen M, Smith-Hansen L, et al. Broadening risk profile in familial colorectal cancer type X; increased risk for five cancer types in the national Danish cohort. BMC Cancer. 2020;20(1):345.
   PubMed Web of Science ®Google Scholar